Axogen Inc vs NextEra Energy, Inc. — how do they compare? Axogen Inc trades at $48.23 (market cap $2.58B), while NextEra Energy, Inc. trades at $86.44 (market cap $179.41B). The key difference: NextEra Energy, Inc. is far larger — about 69.5× Axogen Inc's market cap, and NextEra Energy, Inc. pays a 2.9% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | NEE | |
|---|---|---|
Market Cap | $2.58B | $179.41B |
Sector | Technology | Utilities |
52-Week High | $49.67 | $97.88 |
52-Week Low | $14.79 | $69.77 |
Enterprise Value | $2.49B | $286.75B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.67, up 2.45% today, showing strong momentum near resistance at $50. The stock maintains a bullish technical outlook with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, revenue growth remains robust with Q2 2026 sales up 23.1% to $69.7 million and full-year guidance raised to at least $279 million, but profitability challenges persist with negative net margins and recent earnings misses.
Analyst consensus remains strongly bullish with 84% buy ratings and a $54.33 price target, representing 9.4% upside potential. Key investment opportunities include expanding nerve care platform adoption and reimbursement improvements, while risks include ongoing profitability challenges, competitive pressures, and reliance on elective procedure recovery.
NextEra Energy (NEE) trades at $86.01, up 0.31% on the day, with a bearish technical signal but strong analyst support. Recent earnings show mixed results, with Q4 2025 missing estimates but Q1 and Q2 2026 beating expectations. The company is expanding its role in AI infrastructure, including a $100 billion data center project in Kentucky, driving long-term growth prospects.
The outlook is positive due to robust revenue growth and strategic positioning in AI power demand, though high debt levels and capital expenditures pose risks. Analysts project a consensus price target of $100.40, implying significant upside from current levels, supported by a 66.7% buy rating among coverage firms.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →